Does LEVOMILNACIPRAN Cause Dyspnoea? 81 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Dyspnoea have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 5.9% of all adverse event reports for LEVOMILNACIPRAN.
81
Reports of Dyspnoea with LEVOMILNACIPRAN
5.9%
of all LEVOMILNACIPRAN reports
63
Deaths
66
Hospitalizations
How Dangerous Is Dyspnoea From LEVOMILNACIPRAN?
Of the 81 reports, 63 (77.8%) resulted in death, 66 (81.5%) required hospitalization, and 63 (77.8%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which LEVOMILNACIPRAN Alternatives Have Lower Dyspnoea Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE